These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9494336)

  • 21. [Cardiac sympathetic dysfunction in Parkinson's disease--relationship between results of 123I-MIBG scintigraphy and autonomic nervous function evaluated by the Valsalva maneuver].
    Oka H; Yoshioka M; Morita M; Mochio S; Inoue K
    Rinsho Shinkeigaku; 2003 Aug; 43(8):465-9. PubMed ID: 14658397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk stratification assessed by combined lung and heart iodine-123 metaiodobenzylguanidine uptake in patients with idiopathic dilated cardiomyopathy.
    Kamiyoshi Y; Yazaki Y; Urushibata K; Koizumu T; Kasai H; Izawa A; Kinoshita O; Hongo M; Ikeda U
    Am J Cardiol; 2008 May; 101(10):1482-6. PubMed ID: 18471462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac 123I-MIBG Imaging for Clinical Decision Making: 22-Year Experience in Japan.
    Nakajima K; Nakata T
    J Nucl Med; 2015 Jun; 56 Suppl 4():11S-19S. PubMed ID: 26033897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ¹²³I-MIBG heart-to-mediastinum ratio is influenced by high-energy photon penetration of collimator septa from liver and lung activity.
    Verschure DO; de Wit TC; Bongers V; Hagen PJ; Sonneck-Koenne C; D'Aron J; Huber K; van Eck-Smit BL; Knoll P; Somsen GA; Mirzaei S; Verberne HJ
    Nucl Med Commun; 2015 Mar; 36(3):279-85. PubMed ID: 25415845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Angle of defect on 123I-MIBG myocardial SPECT].
    Terada K; Sugihara H; Tatsukawa H; Keira N; Morimoto S; Inoue K; Katoh S; Nakagawa M
    Kaku Igaku; 1997 Feb; 34(2):113-7. PubMed ID: 9095574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of acquisition time of planar cardiac (123)I-MIBG imaging on the late heart to mediastinum ratio.
    Dimitriu-Leen AC; Gimelli A; Al Younis I; Veltman CE; Verberne HJ; Wolterbeek R; Zandbergen-Harlaar S; Bax JJ; Scholte AJHA
    Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):326-332. PubMed ID: 26515715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of cardiac sympathetic nervous function with left ventricular function and perfusion in cardiomyopathies by (123)I-MIBG SPECT and (99m)Tc-tetrofosmin electrocardiographically gated SPECT.
    Zhao C; Shuke N; Yamamoto W; Okizaki A; Sato J; Ishikawa Y; Ohta T; Hasebe N; Kikuchi K; Aburano T
    J Nucl Med; 2001 Jul; 42(7):1017-24. PubMed ID: 11438621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of therapy for dilated cardiomyopathy with heart failure by iodine-123 metaiodobenzylguanidine imaging: comparison with heart rate variability power spectral analysis].
    Li S; Ikeda J; Takita T; Sekiguchi Y; Demachi J; Chikama H; Goto A; Shirato K
    J Cardiol; 1998 Nov; 32(5):323-9. PubMed ID: 9864689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Assessment of cardiac sympathetic nerve activity in children with chronic heart failure using quantitative iodine-123 metaiodobenzylguanidine imaging].
    Karasawa K; Ayusawa M; Noto N; Sumitomo N; Okada T; Harada K
    J Cardiol; 2000 Dec; 36(6):387-95. PubMed ID: 11190582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic 123I-MIBG SPECT reflects sympathetic nervous integrity and predicts clinical outcome in patients with chronic heart failure.
    Arimoto T; Takeishi Y; Fukui A; Tachibana H; Nozaki N; Hirono O; Yamaguchi H; Itoh M; Miyamoto T; Takahashi H; Okada A; Takahashi K; Kubota I
    Ann Nucl Med; 2004 Apr; 18(2):145-50. PubMed ID: 15195762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical evaluation of no-carrier-added meta-[123I]iodobenzylguanidine for myocardial scintigraphy.
    Knickmeier M; Matheja P; Wichter T; Schäfers KP; Kies P; Breithardt G; Schober O; Schäfers M
    Eur J Nucl Med; 2000 Mar; 27(3):302-7. PubMed ID: 10774882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship of promising methods in the detection of anthracycline-induced cardiotoxicity in breast cancer patients.
    Bulten BF; Verberne HJ; Bellersen L; Oyen WJ; Sabaté-Llobera A; Mavinkurve-Groothuis AM; Kapusta L; van Laarhoven HW; de Geus-Oei LF
    Cancer Chemother Pharmacol; 2015 Nov; 76(5):957-67. PubMed ID: 26400150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age and gender differences in normal myocardial adrenergic neuronal function evaluated by iodine-123-MIBG imaging.
    Tsuchimochi S; Tamaki N; Tadamura E; Kawamoto M; Fujita T; Yonekura Y; Konishi J
    J Nucl Med; 1995 Jun; 36(6):969-74. PubMed ID: 7769454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 123I-MIBG SPECT for Evaluation of Patients with Heart Failure.
    Dimitriu-Leen AC; Scholte AJ; Jacobson AF
    J Nucl Med; 2015 Jun; 56 Suppl 4():25S-30S. PubMed ID: 26033900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of cardiac
    De Vincentis G; Frantellizzi V; Fedele F; Farcomeni A; Scarparo P; Salvi N; Fegatelli DA; Mancone M; Verschure DO; Verberne HJ
    J Nucl Cardiol; 2019 Aug; 26(4):1188-1196. PubMed ID: 29594915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of 123I-metaiodobenzylguanidine in patients with various heart diseases.
    Nagamatsu H; Momose M; Kobayashi H; Kusakabe K; Kasanuki H
    Ann Nucl Med; 2007 Nov; 21(9):513-20. PubMed ID: 18030583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First determination of the heart-to-mediastinum ratio using cardiac dual isotope (¹²³I-MIBG/⁹⁹mTc-tetrofosmin) CZT imaging in patients with heart failure: the ADRECARD study.
    Bellevre D; Manrique A; Legallois D; Bross S; Baavour R; Roth N; Blaire T; Desmonts C; Bailliez A; Agostini D
    Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1912-9. PubMed ID: 26227533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts ventricular arrhythmia in heart failure patients receiving an implantable cardioverter-defibrillator for primary prevention.
    Marshall A; Cheetham A; George RS; Mason M; Kelion AD
    Heart; 2012 Sep; 98(18):1359-65. PubMed ID: 22904144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel method for the assessment of autonomic neuropathy in type 2 diabetic patients: a comparative evaluation of 123I-MIBG myocardial scintigraphy and power spectral analysis of heart rate variability.
    Murata K; Sumida Y; Murashima S; Matsumura K; Takeda H; Nakagawa T; Shima T
    Diabet Med; 1996 Mar; 13(3):266-72. PubMed ID: 8689849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of cardiac sympathetic nerve function by myocardial 123I-metaiodobenzylguanidine scintigraphy before and after endoscopic sympathectomy.
    Toyota S; Takimoto H; Karasawa J; Kato A; Yoshimine T
    J Neurosurg; 2004 Mar; 100(3):512-6. PubMed ID: 15035288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.